Evolving transactional appetites, growth of new therapy areas, emerging supply chain risks and digital transformation are only some of the many issues impacting the growth trajectories of healthcare and life sciences companies globally, while simultaneously contending with complex regulatory regimes and global, local and regional legal pressures. Stay apprised of these developments, trends and opportunities through our dedicated resources hub.

Learn more about our Global Healthcare & Life Sciences Industry Group through the five-minute video below.

 
 



Data PULSE

Protecting and Utilizing Your Data in the Life Sciences Ecosystem

data pulse mock-up

Life sciences companies continue to face a myriad of requirements to ensure compliance with a highly regulated industry environment. As businesses innovate in a digital and data-driven world, the interplay between health and data regulations is becoming increasingly complex and challenging.

Explore Data PULSE, a platform that helps you to navigate the complex landscape of data, regulatory and IP protection concerns throughout various stages of the medical product life cycle.




Explore More Resources

Life Sciences Business Evolution Series: How Digital Transformation and Data Are Shaping Business Models   Life Sciences Business Evolution Series: Funding Growth and the Future of Life Sciences
Life Sciences Report 1   Life Sciences Report 2
Explores how digitally enabled strategies are addressing changing demand and streamlining go-to-market approaches   Looks at how companies are leveraging new and existing sources of growth through transactions
 
     
Life Sciences Business Evolution Series: Shaping Growth - Supply Chains, Manufacturing and Collaboration   Asia Pacific Healthcare and Life Sciences DealSCAPE
Life Sciences Report 3   Healthcare Dealscape cover
Navigates the emerging trends in manufacturing, supply chain, therapy areas and technology partnerships   Explores the defining characteristics of pharmaceutical and biotech transactions in 2022
 
     
The Future of Capital Raising for Biotech & Pharma   Hyper-Hybridity: Defining a New Era of Digital Health Innovation in Asia Pacific
Future of Capital Raising   Hyperhybridity
Navigates the changing landscape of how companies are financing their growth   Looks at the emerging trends and opportunities in digital health ecosystem

 

     
Outside the Comfort Zone: Building Consumer Trust in Digital Healthcare  
Outside the Comfort Zone  
Examines how existing regulatory frameworks accelerate digital health innovation  

 


 
 Chambers Life Sciences Practice Guide 2022    Life Sciences Collaborations
 Chambers Life Sciences Guide 2022    Life Sciences Collaborations
 Offers commentary on legal and business issues in major healthcare and life sciences markets    Issues to consider in executing life sciences collaborations in the COVID-19 era
     
     

Guide to IPOs for Biotech and Pharma Companies

 

Global Guide to Patent Linkage

Guide to IPOs for Biotech and Pharma Companies Report
  Global Guide to Patent Linkage

An overview of the key considerations at each stage of the IPO process

 

Legal regimes covering patent linkage doctrines and enforcement options for drug patent rights holders

 

     
Global Medical Cannabis Survey   Telemedicine and Telehealth Legal Framework Overview
Global Cannabis Dashboard
  Telemedicine survey

An interactive global dashboard on the import and export rules in over 100 markets. Please contact Lilli Meldrum to request access.

 

Addresses recent developments and future outlook across telemedicine and telehealth, providing guidance on drug distribution and e-pharma


 
     
Interacting with Healthcare Professionals
  Promoting Medical Products Globally
Interacting with Healthcare Professionals
  Promoting Medical Products Globally

Regulations and traditional practices governing interactions with healthcare professionals (HCPs)

 

Regulations covering ethical business interactions between medical companies and healthcare professionals


 
     
Brexit: Key Implications for the Healthcare and Life Sciences Sector
  EMEA Digital Health Solutions
Brexit
  EMEA Digital Health Solutions

Key areas in the healthcare and life sciences sector impacted by the UK's new trading relationship with EU

 

Top digital health solutions and legal issues to bear in mind when contemplating a project in the digital sector


 
     
Clinical Trials Handbook
  COVID-19: A Global Review of Healthcare and Life Sciences Industry Issues
Clinical Trials
  Covid-19 Global Review of Healthcare and Life Sciences Industry Issues

Legal framework governing clinical trials of medicinal products in 34 jurisdictions

  A comparative tool that answers questions on market access, clinical trials, IP risks and telemedicine

 
     
UAE: Health Data Law
  Healthcare MapApp 3.0
 UAE Health Data Law    MapApp

Lists the permitted exceptions and conditions to the data transfer restrictions

 

Access real-time information on the laws and regulations in more than 50 countries


 

Healthcare & Life Sciences Supply Chain Series

Focuses on the trends, issues and opportunities along each stage of the supply chain life cycle

Laptop showing healthcare and Life Sciences webinar 

FT Big Deal Series: The Healthtech Sector’s Spectacular Surge in SPACs and de-SPACS

A 3-minute video chat on the rise of SPAC investments in the healthtech sector

Biden Supply Chain Policy Video Series: Episode 5 - Pharmaceuticals and Active Pharmaceutical Ingredients

Discusses the impact of the Biden Administration's policies on FDA regulations and government procurement

LSX Masterclass: Partnering & Licensing

Explores how biotech companies can navigate licensing issues and find the right fit for the future

Global Healthcare & Life Sciences Webinar Series

Aims to share legal industry insights and provide practical guidance

The Health Pod

Looks at sector-specific issues and trends

Connect on Tech Podcast Series

Episode 15: Inside the Global Battle for Healthcare Data

Discusses the regulatory restrictions and M&A considerations when protecting healthcare data

Episode 18: Telehealth and COVID-19: US Privacy Changes and Considerations

Updates to US regulations and enforcement priorities that have evolved in response to the pandemic

3R Podcast Series

Episode 10: The Acceleration of Innovation in Healthcare: The Rise of Digital Health Services

Discusses the roles of the government and corporates in fostering innovation in healthcare

TMT Talk

Episode 9: Digital Transformation: Analysis Using the SMART Framework

Insights on technology hot topics such as healthtech

Visit InsightPlus for our latest legal updates covering healthcare and life sciences developments across the globe

Managing the Healthcare & Life Sciences Supply Chain
Learn more about the important considerations at each stage of the supply chain life cycle for healthcare and life sciences companies, including issues which may arise in the areas of M&A, tax, compliance, trade secrets, digital transformation and ESG.

Sustainability Solutions for the Healthcare and Life Sciences Industries
Identifies the key areas driving the shift in sustainability priorities in the sector

FDA Regulatory Practice
Features our extensive experience in the complex world of products regulated by the FDA, including drugs, medical devices, food, cosmetics, and dietary supplements

Cannabis
Showcases our multidisciplinary offerings to support clients entering, maintaining and expanding their operations within this fast-growing industry

Stay informed
Sign up to receive email updates on our other exciting and upcoming healthcare and life sciences events, publications and webinars.
Subscribe
How We Can Help
As one of the first law firms to advise healthcare and life sciences companies on their global expansion 50 years ago, we remain as one of the top 10 law firms in the world for life sciences cross-border mandates.
Find out more about our services